- $11.45bn
- $16.05bn
- $4.38bn
Deals of the day-Mergers and acquisitions
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout (updated)
Catalent CEO to remain in charge of contract drugmaker after Novo completes buyout
Brief: Catalent Issues Open Letter To Customers Regarding Pending Acquisition By Novo Holdings
Consumer groups ask FTC to block Novo Holdings-Catalent deal (updated)
Consumer groups ask FTC to block Novo Holdings-Catalent deal
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: Catalent Says Ardena Signs Agreement To Expand US Footprint With Acquisition Advanced Drug Product Manufacturing Facility From Co
Brief: Catalent Signs Agreement To Sell Somerset, NJ Oral Solids Facility
Catalent to sell New Jersey facility (updated)
Catalent to sell New Jersey facility
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal (updated)
US Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production
Catalent delays filing of annual report
U.S. STOCKS ON THE MOVE-Catalent, Tesla, Sezzle
U.S. STOCKS ON THE MOVE-Cooper Companies, Catalent, Tesla
Catalent beats revenue estimates ahead of deal close with Novo Holdings (updated)